Medical University of Vienna
Vienna, State of Vienna, 1090, Austria
Location status: Recruiting
Location contact
Andreas Renner, PhD
CONTACT
Gerd Heilemann, PhD
CONTACT
NCT Number: NCT05224297
The project is part of the overarching goal of improving patient-centric radiation oncology. This pilot project aims to develop an instrument that can be used to collect clinically relevant patient-reported outcome data on adverse effects during and after RT. This real-world evidence (RWE) database will be the basis to monitor and evaluate future technological developments, combination treatments (e.g. radioimmunotherapy, etc.), or changes in treatment protocols. The pseudonymized data will be linked to data in the oncological information system and dosimetric data from the treatment planning system. In this way, they represent a basic building block of patient-oriented development of clinical radiotherapy.
Interested in participating?
Request Info18 year–100 year
All sexes
Observational
Vienna, State of Vienna, 1090, Austria
Location status: Recruiting
Andreas Renner, PhD
CONTACT
Gerd Heilemann, PhD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients receive external beam photon therapy for different tumor locations (groups).
Time frame: during radiotherapy and after (up until 5 years)
Contact information is provided by the study sponsor or research team.
Medical University of Vienna
Other
Acronym: PEDRO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04889924
Axillary Lymph Nodes Dissection, Breast Cancer
Sydney, New South Wales, Australia
View Trial DetailsNCT06758830
Chemoradiotherapy, Chemotherapy
Vilnius, Lithuania
View Trial DetailsNCT04986293
Digestive System Diseases, Digestive System Neoplasms
Groningen, Provincie Groningen, Netherlands
View Trial DetailsNCT06618703
Brain Diseases, Brain Neoplasms
Angers, France
View Trial Details